Abnormalities in the Flt3 gene occur in two ways in AML, point mutations in the tyrosine kinase domain and ITDs, which are replicates of three nucleotides that maintain an intact reading frame without disrupting the remainder of the gene (58). This evidence concerns the gene FLT3 and acute myeloid leukemia.